[1]
“ Rituximab in the Treatment of Refractory Myasthenia Gravis : Studying the Outcomes using MMT Score and Need for Plasmapheresis in Baghdad Teaching Hospital ”, Indian Journal of Forensic Medicine & Toxicology, vol. 14, no. 2, pp. 1400–1405, Apr. 2020, doi: 10.37506/ijfmt.v14i2.3108.